Skadden, Arps, Slate, Meagher & Flom and Zhong Lun Law Firm have advised China’s Everest Medicines on its $451 million IPO in Hong Kong, with Kirkland & Ellis and Tian Yuan Law Firm advising the joint sponsors and underwriters.
Davis Polk & Wardwell and Cyril Amarchand Mangaldas have advised Reliance Industries on its $2.6 billion sale of stakes in its retail unit to Singapore sovereign wealth fund GIC, global private equity firm TPG Capital, Abu Dhabi Investment Authority (ADIA) and Mubadala Investment Company.
Skadden, Arps, Slate, Meagher & Flom has advised Shanghai-based biopharmaceutical company JHBP (CY) Holdings, a holding company for Genor Biopharma, on its HK $2.87 billion ($371 million) IPO in Hong Kong, with Kirkland & Ellis representing the joint sponsors and the underwriters.
U.S. law firm Orrick, Herrington & Sutcliffe has advised Japan's largest mobile phone operator Docomo, publicly listed some 28 years ago, on a 4.25 trillion yen ($40 billion) tender offer by its parent company NTT to take it private.
Davis Polk & Wardwell has advised Ming Yuan Cloud Group on its HK$6.2 billion ($797 million) IPO on the Hong Kong Stock Exchange, with Freshfields Bruckhaus Deringer representing the joint sponsors and underwriters.
Cleary Gottlieb Steen & Hamilton and JunHe have advised Chinese hotel management company Huazhu Group on its $783 million secondary listing on the Hong Kong Stock Exchange, with Freshfields Bruckhaus Deringer and Jingtian & Gongcheng representing the underwriters.
Skadden, Arps, Slate, Meagher & Flom and Global Law Office Shanghai have advised Chinese courier ZTO Express on its $1.55 billion secondary listing on the Hong Kong Stock Exchange, with Freshfields Bruckhaus Deringer and JunHe counselling the sponsor and the underwriters.
Davis Polk & Wardwell, Zhong Lun Law Firm and have advised Chinese biopharmaceutical company Zai Lab’s on its $761 million secondary listing on the mainboard of the Hong Kong Stock Exchange, with Simpson Thacher & Bartlett and Commerce & Finance Law Offices advising the underwriters.
Slaughter and May has advised British insurer Aviva on the S$2.7 billion ($1.98 billion) sale of majority shares in its Singapore business to a consortium led by Singapore Life (Singlife). Allen & Gledhill advised on the Singapore law aspects of the transaction.